Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Globus Medical stock
Learn how to easily invest in Globus Medical stock.
Globus Medical Inc is a medical devices business based in the US. Globus Medical shares (GMED) are listed on the NYSE and all prices are listed in US Dollars. Globus Medical employs 2,200 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Globus Medical
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GMED – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Globus Medical stock price (NYSE: GMED)Use our graph to track the performance of GMED stocks over time.
Globus Medical shares at a glance
|Latest market close||$63.68|
|52-week range||$59.37 - $84.23|
|50-day moving average||$69.72|
|200-day moving average||$74.76|
|Wall St. target price||$88.21|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.82|
Buy Globus Medical shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Globus Medical stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Globus Medical price performance over time
|1 week (2022-01-18)||N/A|
|1 month (2021-12-27)||-12.99%|
|3 months (2021-10-29)||-17.48%|
|6 months (2021-07-29)||-23.63%|
|1 year (2021-01-29)||3.23%|
|2 years (2020-01-29)||19.88%|
|3 years (2019-01-29)||46.59%|
|5 years (2017-01-27)||144.36%|
Is Globus Medical stock undervalued or overvalued?
Valuing Globus Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globus Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Globus Medical's P/E ratio
Globus Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Globus Medical shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Globus Medical's PEG ratio
Globus Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.7087. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Globus Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Globus Medical's EBITDA
Globus Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $299.2 million.
The EBITDA is a measure of a Globus Medical's overall financial performance and is widely used to measure a its profitability.
Globus Medical financials
|Revenue TTM||$941.5 million|
|Operating margin TTM||24.35%|
|Gross profit TTM||$571.6 million|
|Return on assets TTM||8.3%|
|Return on equity TTM||11.93%|
|Market capitalisation||$6.9 billion|
TTM: trailing 12 months
Globus Medical share dividends
We're not expecting Globus Medical to pay a dividend over the next 12 months.
Globus Medical share price volatility
Over the last 12 months, Globus Medical's shares have ranged in value from as little as $59.365 up to $84.23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globus Medical's is 1.1095. This would suggest that Globus Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Globus Medical overview
Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Globus Medical in the news
Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
Ackman takes a big stake in Netflix, excited about company's long-term prospects
What to watch today: Stock futures turn positive, reversing big overnight losses
Frequently asked questionsWhat percentage of Globus Medical is owned by insiders or institutions?
Currently 0.846% of Globus Medical shares are held by insiders and 69.751% by institutions. How many people work for Globus Medical?
Latest data suggests 2,200 work at Globus Medical. When does the fiscal year end for Globus Medical?
Globus Medical's fiscal year ends in December. Where is Globus Medical based?
Globus Medical's address is: 2560 General Armistead Avenue, Audubon, PA, United States, 19403 What is Globus Medical's ISIN number?
Globus Medical's international securities identification number is: US3795772082 What is Globus Medical's CUSIP number?
Globus Medical's Committee on Uniform Securities Identification Procedures number is: 379577208
More guides on Finder
Cathie Wood’s ARK analysts predict Bitcoin at $1 million each by 2030
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market has lost $1.5 trillion in value — time to buy?
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin tumbles past $40,000, altcoins follow
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s Pavia plot sale shows land rush is on in the metaverse
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Ask an Expert